Background The intestinal permeability is increased in patients with diarrhoea‐predominant
irritable bowel syndrome (D‐IBS). Aim To determine the possible efficacy of lactic acid …

There is increasingly convincing evidence supporting the participation of the gut
microenvironment in the pathophysiology of irritable bowel syndrome (IBS). Studies …

Background: The clinical effect of probiotics on irritable bowel syndrome (IBS) is still
controversial. Aims: We aimed to evaluate the effects of a probiotic mixture on IBS symptoms …

Background/Aims: Defective epithelial barrier has been implicated in the pathogenesis of
irritable bowel syndrome (IBS) and inflammatory bowel diseases. The aim of this study was …

Objective To discuss the role of gut dysbiosis in the development of irritable bowel syndrome
(IBS) and the impact of probiotics as a potential therapeutic measure. Methods PubMed was …

The effect of probiotics on small intestinal bacterial overgrowth (SIBO) in irritable bowel
syndrome (IBS) has never been studied so far. In this prospective trial, five patients with IBS …

Methods Forty patients were randomly allocated to be treated with Medilac DS (Bacillus
subtilis, Streptococcus faecium)(n= 20) or placebo (n= 20) in a double-blind, prospective …

Irritable bowel syndrome (IBS) is a common and chronic gastrointestinal disorder. Probiotics
may have the potential to impact the management of IBS; however, the results of trials are …

Background Gut microflora‐mucosal interactions may be involved in the pathogenesis of
irritable bowel syndrome (IBS). Aim To investigate the efficacy of a novel prebiotic trans …

The irritable bowel syndrome (IBS) follows an acute, presumably infectious diarrheal illness
in∼ 15% of patients. There may be a persistent, mild inflammatory state with changes in …